• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL - NEUROMODULATION LIBRAXP PULSE GENERATOR, DUAL 4-CHANNEL; DBS IPG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL - NEUROMODULATION LIBRAXP PULSE GENERATOR, DUAL 4-CHANNEL; DBS IPG Back to Search Results
Model Number 6644
Device Problem Device Inoperable (1663)
Patient Problems Loss of Range of Motion (2032); Inadequate Pain Relief (2388)
Event Date 05/26/2015
Event Type  Injury  
Event Description
It was reported the patient ((b)(6)) abruptly loss stimulation and experienced a sudden deterioration of mobility.Diagnostics revealed the patient's ipg was depleted.Additionally, it was noted by the physician that the patient's ipg depleted prematurely.Subsequently, the patient was hospitalized on (b)(6) 2015 and underwent surgical intervention on (b)(6) 2015 to explant and replace the ipg.Therapy was restored post-operative.
 
Manufacturer Narrative
(b)(4).This device is not approved for sale in the usa, but is similar to a usa marketed/approved device.(b)(4).Sjm has limited information related to the patient's medical history and is unable to form an opinion as to the relevancy of the patient's history to the event reported.Sjm defers to the patient's physician regarding medical history.
 
Manufacturer Narrative
Evaluation: results: a visual inspection of the ipg did not reveal any discrepancies.Communication with the device as received was unsuccessful when using a patient programmer and wdl utility.With the device attached to an external supply, it was subjected to a functional test on automated test equipment (ate).This tester verifies the electrical performance of the control/communication circuitry, and output signal integrity.All portions of ate testing passed.Based on the available information, the estimated longevity was 35 months.The device provided 31 months of stimulation at the time of the observation, and had exceeded 88% of the estimated longevity, which is beyond the minimum requirement of 75%.Sjm has limited information related to the patient's medical history and is unable to form an opinion as to the relevancy of the patient's history to the event reported.Sjm defers to the patient's physician regarding medical history.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBRAXP PULSE GENERATOR, DUAL 4-CHANNEL
Type of Device
DBS IPG
Manufacturer (Section D)
ST. JUDE MEDICAL - NEUROMODULATION
6901 preston rd
plano TX 75024
Manufacturer (Section G)
ST. JUDE MEDICAL - NEUROMODULATION
6901 preston rd
plano TX 75024
MDR Report Key4860054
MDR Text Key5872735
Report Number1627487-2015-25111
Device Sequence Number1
Product Code GZB
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P010032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/23/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/28/2014
Device Model Number6644
Device Lot Number3776129
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/23/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/23/2015
Initial Date FDA Received06/22/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/14/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/13/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age67 YR
-
-